T. Rowe Price Associates
RBOT

T. Rowe Price Associates’s Vicarious Surgical RBOT Stock Holding History

T. Rowe Price Associates’s Portfolio RBOT Stock Details RBOT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-1,027
Closed -$10K – 3007
2024
Q1 		$10K Buy
1,027
+558
+119% +$6.66K ﹤0.01% 2943
2023
Q4 		$6K Hold
469
– – ﹤0.01% 2895
2023
Q3 		$9K Buy
469
+47
+11% +$1.71K ﹤0.01% 2871
2023
Q2 		$24K Buy
+422
New +$26.9K ﹤0.01% 2859

Other funds holding RBOT

VS
VK Services Menlo Park, California $543K AUM 174.84% 1-Year Est. Return
DP
DDD Partners Bellevue, Washington $1.6B AUM 17.6% 1-Year Est. Return
MAMHA
MY.Alpha Management HK Advisors Hong Kong $246M AUM 73.75% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AMH
Aspex Management (HK) Central, Hong Kong $6.9B AUM 28.37% 1-Year Est. Return
CFM
Comprehensive Financial Management Los Gatos, California $3.01B AUM 2.93% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Associates's RBOT Position: Q2 2024 in Review

T. Rowe Price Associates sold out of Vicarious Surgical (RBOT) in Q2 2024, closing a stake of 1,027 shares — an estimated $10K sold.

T. Rowe Price Associates first reported a position in RBOT in Q2 2023 and held it in 4 quarters. The position peaked at $24K in Q2 2023. 38 funds tracked by Wall St. Rank hold RBOT as of Q2 2024.

  • T. Rowe Price Associates reported no remaining Vicarious Surgical position as of Q2 2024 after selling out during the quarter.
  • T. Rowe Price Associates sold 1,027 Vicarious Surgical shares in Q2 2024, an estimated $10K.
  • T. Rowe Price Associates first reported a position in Vicarious Surgical in Q2 2023 and held it in 4 quarters.
  • T. Rowe Price Associates's Vicarious Surgical position peaked at $24K in Q2 2023.
  • 38 funds tracked by Wall St. Rank held Vicarious Surgical as of Q2 2024.

Based on T. Rowe Price Associates's 13F filing for Q2 2024, filed 14 Aug 2024.